Two departments: actively promote the inclusion of innovative drugs in the commercial health insurance guarantee range, and enhance the management of medical insurance payment scope.
Actively promote the inclusion of innovative drugs in the commercial insurance drug list into the scope of commercial health insurance coverage. Local medical insurance departments should work together with relevant departments to promote the construction of a multi-level medical security system, actively support the development of universal commercial health insurance, and recommend the use of commercial health insurance, medical mutual aid, and other multi-level medical security systems for the commercial insurance drug list.
On December 7th, the National Medical Insurance Administration and the Ministry of Human Resources and Social Security issued the "National Basic Medical Insurance, Maternity Insurance, and Work-related Injury Insurance Drug List" and the "Commercial Health Insurance Innovative Drug List" (2025). The new version of the drug list will officially take effect on January 1, 2026, and the "National Basic Medical Insurance, Work-related Injury Insurance, and Maternity Insurance Drug List (2024)" (Medical Insurance No.202433) will be simultaneously abolished.
It is proposed that efforts should be made to actively promote the inclusion of innovative drugs in the commercial health insurance coverage. Local medical insurance departments should work with relevant departments to promote the construction of a multi-level medical security system, actively support the development of universal commercial health insurance, and recommend the use of innovative drugs in the commercial health insurance and medical mutual aid systems. Support commercial health insurance institutions to design new products, update reimbursement ranges, adjust reimbursement methods based on the innovative drug list, better meet the medication needs of patients, and effectively reduce the burden of medical expenses on patients. Encourage regions with conditions to explore the implementation of a "one-stop" settlement system for medical insurance, work-related injury insurance, and commercial health insurance.
The article goes on to provide guidelines and procedures for the implementation of the new drug list, the management of drug payment standards under the medical insurance, and strategies to improve the supply guarantee level of medical insurance drugs.
---
This is a detailed document discussing the issuance of new drug lists in the context of national medical insurance in China. It covers various aspects such as the implementation of new drug lists, management of drug payment standards, and measures to improve the supply of medical insurance drugs.
Related Articles
Sticking too close becomes a resistance? The path of the Federal Reserve Chairman Haslet is changing, Washington's presence is increasing.
.png)
Fannie Mae and Freddie Mac quietly increased their holdings of tens of billions in mortgage-backed securities, paving the way for lower interest rates and an IPO.

The market is back to the "bad news is good news" logic! Soft non-farm data = higher rate cut probability, U.S. stocks and bonds are expected to receive support.
Sticking too close becomes a resistance? The path of the Federal Reserve Chairman Haslet is changing, Washington's presence is increasing.
Fannie Mae and Freddie Mac quietly increased their holdings of tens of billions in mortgage-backed securities, paving the way for lower interest rates and an IPO.
.png)
The market is back to the "bad news is good news" logic! Soft non-farm data = higher rate cut probability, U.S. stocks and bonds are expected to receive support.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


